Suppliers / Royal Pharmaceuticals

Royal Pharmaceuticals

United States 65 employees Updated 9 July 2026

Royal Pharmaceuticals is a finished-dose manufacturer based in United States. It appears in 4 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA and EDA (EG).

0
active US DMFs
0
valid CEPs
0
registered plants
4
filings across 2 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 3 None
EDA (EG) 1 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Royal Pharmaceuticals

Does Royal Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Royal Pharmaceuticals. It does have 4 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Royal Pharmaceuticals file?
Filings are on record with US FDA and EDA (EG), 4 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Royal Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability